Seeking Alpha

Molycorp, Inc. (MCP)

  • Jan. 10, 2013, 9:10 AM
    Premarket gainers: NOK +20%. SVU +19%. NEWL +18%. QLIK +8%. CRUS +7%. STM +5%.
    Losers: MCP -12%. ASNA -12%. ARO -9%. TIF -8%.
    | Comment!
  • Jan. 10, 2013, 7:49 AM
    Molycorp (MCP) slides 8.7% premarket as the company warns its 2013 revenue and cash flow will far short of expectations. "(The company) is evaluating its capital needs." (PR)
    | 1 Comment
  • Jan. 7, 2013, 7:27 AM
    China sets at 46.9K metric tons its first rare earth production quota for 2013 - roughly half the level of 2012. Molycorp (MCP) gains 3% premarket, also helped by Lawrence Balter putting the stock on his list of 2013 underdogs to surprise. The bad news and then some is baked in, he says, keeping his $50 price target on the shares.
  • Jan. 2, 2013, 8:12 AM
    Molycorp (MCP) +7.3% premarket, as the company’s low valuation and the chance to lock in rare-earth resources could make it a potential takeover target, Bloomberg reports. Analysts say manufacturers from Nissan (NSANY.OB) to Siemens (SI) could be interested, and shares could fetch $15 in a takeover.
    | 1 Comment
  • Dec. 12, 2012, 9:10 AM
    Premarket gainers: YMI +79%. DSTI +15%. SCMP +11%. ACAD +9%. BGMD +10%.
    Losers: RSOL -16%. CIE -11%. MCP -6%.
    | Comment!
  • Dec. 12, 2012, 9:06 AM
    Despite the immediate negative reaction to the ouster of Molycorp (MCP) CEO Mark Smith - shares -5.5% premarket - investors may come around to a more positive view. Smith "had lost credibility" with constituents, shareholders, potential investors and analysts, a J.P. Morgan analyst says; "his ability to deal with the financials of an emerging company appeared to overwhelm him at times," says another.
  • Dec. 11, 2012, 5:17 PM
    Conspicuously absent from Mark Smith's resignation announcement was any mention of the SEC investigation over the accuracy of Molycorp's (MCP) disclosures. The take from 24/7's Jon Ogg: "To announce that a CEO has left the company with no explanation in the midst of a regulatory investigation is not in good taste at all. It could even be alarming." MCP -5.3% AH.
  • Dec. 11, 2012, 4:32 PM
    Molycorp (MCP) says CEO Mark Smith has resigned; no explanation is offered. Board vice chairman Constantine Karayannopoulos is named interim president and chief executive. Shares -6.3% AH.
  • Dec. 11, 2012, 4:00 PM
    Molycorp (MCP +5.8%) posts its second straight strong gain, as the picture grows brighter: Large stockpiles of rare earths are finally starting to dwindle, and top competitor Lynas is undergoing regulatory problems with Malaysia's government. How much higher can MCP climb? Oracle's Laurence Balter has a $50 price target, but shares still would be shy of their 2011 summer high near $7.
  • Dec. 10, 2012, 3:19 PM
    Lynas' (LYSCF.PK, LYSDY.PK) plans to ramp up rare earth materials via its new Malaysian plant suffer a setback, as four ministers say it must export waste material in Malaysia or risk having its operating license revoked. The ministers' statement followed reports citing Lynas Malaysia's director as saying the company would not export residue from the plant. MCP +19.8%, AVL +10%, REE +9.5%.
  • Dec. 10, 2012, 11:35 AM
    Molycorp (MCP +15.7%) soars, taking the rest of the rare earth sector with it (AVL +6.2%, REE +11%, REMX +1.7%). Traders describe the move as the continuation of a short squeeze in Molycorp - whose shares dropped below 6 in mid-November after being in the mid-30s 7 months earlier. Adding fuel is a report Interactive Brokers has said there is insufficient stock available for short sales.
  • Nov. 23, 2012, 12:45 PM
    Midday top 10 gainers: CCCL +42%. MAPP +21%. BGMD +21%. MCP +18%. INUV +16%. FIZZ +15%. ROSG +14%. DAC +13%. RIMM +13%. RIC +12%.
    Top 10 Losers: KITD -64%. PTGI -17%. SGOC -12%. HDSN -9%. TELK -9%. SAB -8%. HRT -8%. NFEC -8%. THQI -7%. RCON -7%.
    | 1 Comment
  • Nov. 23, 2012, 9:09 AM
    Molycorp (MCP) +4.3% premarket on news of new insider buying; a director and a vice president bought a combined ~55K shares at $6.20-$7.10, worth ~$400K.
  • Nov. 13, 2012, 10:21 AM
    Molycorp (MCP -2.2%) moves lower again after Morgan Stanley downgrades shares to Equal Weight following Friday's disclosure of a formal order of SEC investigation. While it's possible the worst case scenario already is priced in, the firm says uncertainty surrounding the issue and the possibility that it will take some time to resolve leads to the downgrade.
  • Nov. 12, 2012, 10:18 AM
    After slumping 13% Friday on disclosure of a SEC investigation, Molycorp (MCP -9%) continues lower today. Dahlman Rose also notes MCP reported a $150M increase in capital expenditures; the firm sees 2013 as a transitional year, where cash management and project execution will be crucial in unlocking the value of Mountain Pass without the need for additional capital.
  • Nov. 9, 2012, 11:38 AM
    Molycorp (MCP -4.4%) resumes trading after a brief halt, as an SEC filing discloses an SEC investigation regarding the accuracy of disclosures of certain sales of stock by officers, directors and private equity firms, as well as certain corporate acquisitions during 2011.
Visit Seeking Alpha's
MCP vs. ETF Alternatives
Company Description
Molycorp, Inc., manufactures custom engineered rare earth and rare metal products. The Company's reportable segments include resources chemicals and oxides magnetic materials and alloys and rare metals.